Closed-Loop O2 Use During High Flow Oxygen Treatment of Critical Care Adult Patients (CLOUDHFOT)

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

March 21, 2024

Primary Completion Date

December 30, 2025

Study Completion Date

May 30, 2026

Conditions
Acute Hypoxemic Respiratory FailureAcute Hypercapnic Respiratory FailureRespiratory DepressionRespiratory Failure
Interventions
DEVICE

Closed-loop FiO2 controller

Close-loop FiO2 controller software option provides automated adjustment of the ventilator Oxygen setting to maintain the patient's SpO2 in a defined target range. When using the software option, the user defines the SpO2 target range, as well as the SpO2 emergency limits, and the device adjusts the FiO2 setting to keep the patient's SpO2 in the target range.

DEVICE

Conventional

Six hours period where the fraction of inspired oxygen (FiO2) delivered will be manually titrated by clinician based on SpO2 values obtained from the patient.

Trial Locations (2)

35230

RECRUITING

Dr.Suat Seren Chest Diseasees Hospital, Izmir

Unknown

RECRUITING

Başakşehir Çam & Sakura City Hospital, Istanbul

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Hamilton Medical AG

INDUSTRY

lead

Başakşehir Çam & Sakura City Hospital

OTHER_GOV